Status:
UNKNOWN
The Effect of Digital Reminiscence Therapy on People With Mild and Moderate Dementia
Lead Sponsor:
National Taipei University of Nursing and Health Sciences
Conditions:
Dementia
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
In the post-epidemic era, it is necessary to develop support programs for families with dementia in empirical care. The reminiscence therapy was adopted by patients with mild and moderate dementia tho...
Detailed Description
In the post-epidemic era, it is necessary to develop support programs for families with dementia in empirical care. The reminiscence therapy was adopted by patients with mild and moderate dementia tho...
Eligibility Criteria
Inclusion
- The conditions for accepting cases for families with dementia are as follows:
- Family caregivers must meet the following conditions:
- ①Age 20 years old or above
- ②Have experience in caring for the dementia case in the past year, and live together
- Have a smart phone and have experience in using line APP
- Dementia patients must meet the following conditions:
- Those who currently live at home and regularly go to the Rizhao Center to participate in activities ②Patients with dementia (Alzheimer's disease) diagnosed by a physician with DSM 5 or in line with NINCDS/ADRDA, their CDR score is 1\~2 points ③ Those who have a clear consciousness, can express in Chinese and Taiwanese, or communicate with others in words without hindrance ④ Those who have normal vision and hearing, and can operate digital mobile phones or tablets
Exclusion
- The exclusion criteria for families with dementia are:
- The exclusion conditions for family caregivers are:
- A history of mental illness diagnosed by a psychiatrist, such as major depression ② Those who are not of their own nationality.
- The exclusion conditions for patients with dementia are:
- Confusion or delirium ② Dementia cases who will be referred to long-term care institutions or nursing homes within one month.
Key Trial Info
Start Date :
January 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2023
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT05341271
Start Date
January 21 2022
End Date
July 31 2023
Last Update
April 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taipei University of Nursing and Health Sciences
Taipei, Taipei City, Taiwan, 112303